WWWiktoria Wiśniewska

Wiktoria Wiśniewska

*This is an algorithmically generated author record based on publicly available information.

Wiktoria Wiśniewska has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    NEUROMODULATION IN PEDIATRIC OBSESSIVE-COMPULSIVE DISORDER: A SYSTEMATIZED NARRATIVE REVIEW EMPHASIZING SEVERE AND TREATMENT-RESISTANT PRESENTATIONS

    by Laura Mikuła, Julia Sposób, Justyna Strycharczuk, Wiktoria Wiśniewska, Wiktoria Jarosiewicz, Aleksandra Kowalewska-Kurek, Katarzyna Kowalska, Daria Krzyżanowska

    Objective: Pediatric obsessive-compulsive disorder (OCD) is usually managed with cognitive-behavioral therapy with exposure and response prevention and selective serotonin reuptake inhibitors, yet a subset of patients remains severely symptomatic. This review evaluates the pediatric evidence for transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS) and deep brain stimulation (DBS), with emphasis on severe or treatment-resistant OCD. Methods: We conducted a systematic narrative review of English-language literature published between 2015 and 2025. Searches were performed in PubMed/MEDLINE and Google Scholar and supplemented by reference-list screening. Eligible sources included pediatric or adolescent clinical studies, case reports, protocols and implementation-relevant ethical or developmental literature concerning TMS, tDCS, or DBS for OCD. Results: Twenty-eight records were included. Pediatric evidence was sparse and heterogeneous, with few controlled data and limited follow-up. TMS was the most frequently described modality and was supported mainly by observational studies, case reports, and extrapolation from adult OCD literature. One sham-controlled adolescent tDCS trial reported improvement in both active and sham groups, without clear between-group superiority. No prospective pediatric DBS trials for primary OCD were identified; available evidence was limited to isolated cases, comorbid neuropsychiatric cohorts, and stakeholder or ethics studies. Conclusions: Current evidence does not support routine neuromodulation for pediatric OCD. TMS appears closest to cautious clinical translation in specialist settings, whereas tDCS should remain research-focused. DBS should be restricted to exceptional, severe, treatment-refractory cases under multidisciplinary review, robust ethical oversight and developmentally appropriate consent or assent procedures.

  • Open Access

    The impact of the endometrial microbiome on IVF outcomes – current evidence

    by Anna Malczyk, Damian Zienkiewicz, Gabriela Makulec, Karolina Domosud, Weronika Walendziak, Natalia Mordal, Kacper Ściebura, Wiktoria Wiśniewska, Magdalena Ostaszewska, Milena Majchrzyk

    Background: The uterine cavity, previously considered as an aseptic physiological milieu isnow recognized as host to a distinct endometrial microbial community (EM). This analysisaims to elucidate the influence of the EM taxonomic configuration on female reproductivemorbidity, with particular emphasis on its implications for Recurrent Implantation Failure(RIF). Furthermore, the study assesses the prognostic value of the EM profile in determiningclinical outcomes following Assisted Reproductive Technologies (ART), specifically In VitroFertilization (IVF).Aim: This systematic review was designed to elucidate the correlation between themetagenomic composition of the endometrial microbiome and female infertility.Material and methods: The methodology centered on the comprehensive identification andrigorous critical appraisal of clinical evidence archived within the PubMed/ MEDLINE andthe Cochrane Library.Summary: The presence of a eubiotic Lactobacillus-dominated (LD) endometrialmicrobiome (EM) is highly correlated with optimized endometrial receptivity andsubsequently elevated rates of successful implantation, continuation of pregnancy, and livebirth following assisted reproductive technology (ART) procedures. Conversely, anendometrial dysbiotic state, often characterized as non-Lactobacillus-dominated (non-LD)EM, is consistently associated with a substantial reduction in reproductive success. Studies ofpatients with recurrent implantation failure (RIF) identified a significantly higher relativeabundance of various pathogenic bacterial genera in the EM compared with control subjects.Although the endometrial abundance of Lactobacillus did not differ significantly betweenwomen with RIF and control subjects, reduced vaginal Lactobacillus rates in the RIF groupcompared to controls suggest that vaginal concentrations may represent a potential biomarkerfor RIF.

  • Open Access

    Physical Activity in Polycythemia Vera: Benefits, Risks and Evidence-Based Exercise Recommendations - A Narrative Review

    by Kacper Ściebura, Natalia Mordal, Damian Zienkiewicz, Gabriela Makulec, Karolina Domosud, Weronika Walendziak, Wiktoria Wiśniewska, Magdalena Ostaszewska, Milena Majchrzyk, Anna Malczyk

    Background. Polycythemia vera (PV) is a type of Philadelphia-negative myeloproliferative neoplasm (MPN) associated with a good prognosis but possible serious complications. Although medications lower hematocrit and reduce thrombosis risk, patients and clinicians underuse non-drug approaches such as physical activity (PA), despite growing evidence for their help while dealing with the disease’s symptoms and complications. Aim: This study aims to identify and evaluate the safest and most effective types of physical activity specifically recommended for patients diagnosed with PV. Methods: A brief review of studies examining physical activity in patients with PV or other MPNs was conducted using PubMed, ScienceDirect, American Society of Hematology publications and Google Scholar. Results: Regular PA of moderate intensity, such as walking, swimming, or cycling, for 150–300 minutes per week is safe in well-controlled PV (hematocrit < 45%). This level of activity reduces the most common PV complication - fatigue - by 30–50%, but also soothes aquagenic pruritus, especially during water-based exercise, helps with concentration problems, and decreases bone or muscle pain. Discussion and conclusions: Tailored physical activity for patients with polycythemia vera shows promising results in reducing common symptoms. However, further research is needed to develop optimal activity recommendations for all patient groups.

  • Open Access

    Dry Eye Disease in Physically Active Individuals: The Role of Environmental Factors – A Narrative Review

    by Natalia Mordal, Kacper Ściebura, Weronika Walendziak, Damian Zienkiewicz, Gabriela Makulec, Karolina Domosud, Wiktoria Wiśniewska, Magdalena Ostaszewska, Milena Majchrzyk, Anna Malczyk

    Background. Dry eye disease (DED) is a multifactorial disorder of the ocular surface characterized by tear film instability, hyperosmolarity, inflammation, and neurosensory abnormalities. Environmental stressors and systemic factors play a significant role in its development. Physically active individuals are likely to be exposed to such conditions. Aim. To summarize current evidence on the impact of environmental factors and hydration on the development and severity of dry eye disease, with emphasis on physically active populations. Materials and methods. A narrative review was conducted using literature indexed in PubMed and Google Scholar databases, including studies published between 2001 and 2024. The publications were selected based on their relevance to epidemiology and pathophysiology. Results. DED affects a substantial proportion of the population worldwide. Environmental factors such as low humidity, air pollution, temperature variations, ultraviolet radiation and dehydration contribute to ocular surface stress. These factors influence tear osmolarity and may exacerbate symptoms, particularly in physically active individuals exposed to increased environmental and physiological stress. Conclusions. Environmental exposure and hydration status are important contributors to dry eye disease. Physically active individuals may be at increased risk due to combined exposure to environmental conditions and fluid imbalance, highlighting the importance of preventive strategies in this population.

  • Open Access

    3,4-Methylenedioxymethamphetamine: From Dangerous Party Drug to Potential Therapeutic Agent

    by Magdalena Ostaszewska, Milena Majchrzyk, Damian Zienkiewicz, Gabriela Makulec, Karolina Domosud, Weronika Walendziak, Natalia Mordal, Kacper Ściebura, Wiktoria Wiśniewska, Anna Malczyk

    Introduction and aim of the study: 3,4-methylenedioxymethamphetamine (MDMA) is a stimulant drug with widespread consumption. It is used mainly in recreational settings, due to its ability to induce various pleasurable, mood-enhancing effects. Prolonged and excessive MDMA misuse can lead to multiple negative outcomes ranging from cognitive dysfunction or emotional dysregulation to severe life-threatening consequences such as hyperthermia. Despite its harmful potential, MDMA presents promising therapeutic applications in MDMA-Assisted Therapy. In this study we aim to review both the dangers and potential psychiatric applications of MDMA. Materials and methods: A literature search was conducted using databases such as PubMed and Google Scholar. The review focused on peer-reviewed articles and international reports regarding the use of MDMA, both recreational and in the treatment of various psychiatric conditions. Conclusions: While MDMA has traditionally been associated mainly with recreational use and addiction, research suggests it has the potential to become a valuable therapeutic adjunct in treating such psychiatric conditions as PTSD, alcohol dependence, depression and anxiety. Furthermore, it could be beneficial in the athletic populations. However, existing studies are limited by small sample sizes, highlighting the need for further large-scale research to confirm these findings.Keywords: MDMA, MDMA-Assisted Therapy, PTSD, alcohol dependence, depression, anxiety, mental health of athletic populations

  • Open Access

    Physical Activity and the Glymphatic System: Potential Interactions and Implications for Brain Health

    by Gabriela Makulec, Karolina Domosud, Damian Zienkiewicz, Magdalena Ostaszewska, Weronika Walendziak, Natalia Mordal, Kacper Ściebura, Wiktoria Wiśniewska, Milena Majchrzyk, Anna Malczyk

    Background: The glymphatic system is a perivascular network that promotes the exchange of cerebrospinal fluid (CSF) and interstitial fluid (ISF) and assists the elimination of metabolic waste products from the central nervous system. Aim: The aim of this narrative review was to summarise current evidence regarding possible interactions between physical activity and glymphatic function. Methods: A literature search was conducted in PubMed to identify studies addressing glymphatic transport, CSF dynamics, and physiological adaptations associated with exercise. Results: The majority of research on the effect of exercise on the glymphatic system is from experimental studies using animal models, which have found that voluntary exercise is associated with increased influx and clearance of interstitial solutes. These effects have also been linked to improved vascular health, decreased neuroinflammation, alterations in aquaporin-4 polarisation, and improved sleep health, including increased slow-wave sleep. Recent neuroimaging findings in human research suggest that long-term physical activity is connected with increased MRI measurements of glymphatic and meningeal lymphatic flow. Conclusions: These findings are all derived from indirect imaging methods, and many studies indicate that physical activity affects multiple physiological pathways involved in glymphatic transport. Further studies combining exercise interventions with advanced neuroimaging approaches are needed to clarify whether and how physical activity influences glymphatic function in the human brain.

  • Open Access

    The Efficacy and Safety of Ibogaine Treatment for Substance Use Disorders - A Narrative Review

    by Milena Majchrzyk, Weronika Walendziak, Magdalena Ostaszewska, Damian Zienkiewicz, Gabriela Makulec, Karolina Domosud, Natalia Mordal, Kacper Ściebura, Wiktoria Wiśniewska, Anna Malczyk

    Introduction and aim of the study. Substance use disorders, including opioid, cocaine, and alcohol dependence, represent a significant global health challenge with high relapse rates despite existing treatments. Ibogaine, a naturally occurring indole alkaloid derived from Tabernanthe iboga, has attracted increasing scientific interest due to its reported ability to reduce withdrawal symptoms and cravings. Our study aims to evaluate the efficacy and safety of ibogaine in the treatment of substance use disorders and to determine its therapeutic potential. Materials and methods. The paper is based on an analysis of studies available in databases such as PubMed, Google Scholar, and other scientific databases. Observational studies, retrospective surveys, controlled trials, and review papers on the use of ibogaine in the context of opioid, cocaine, and alcohol dependence were used. Conclusions. Ibogaine, due to its modulation of serotonergic, dopaminergic, and glutamatergic neurotransmitter systems, shows promising potential in the treatment of substance use disorders. However, serious safety concerns exist, particularly cardiotoxicity manifesting as QT prolongation and potentially fatal arrhythmias. It is advisable to conduct further large-scale randomized controlled trials aimed at a more thorough evaluation of the efficacy and safety of ibogaine in the treatment of addiction.


  • Open Access

    Can environmental changes modify the manifestations of cutaneous diseases, and via what mechanism?

    by Karolina Domosud, Weronika Walendziak, Gabriela Makulec, Magdalena Ostaszewska, Damian Zienkiewicz, Natalia Mordal, Kacper Ściebura, Wiktoria Wiśniewska, Milena Majchrzyk, Anna Malczyk

    Can environmental changes modify the manifestations of cutaneous diseases and via what mechanism?

  • Open Access

    PSYCHOLOGICAL BURDEN IN RENAL REPLACEMENT THERAPY: COMPARATIVE OUTCOMES ACROSS HEMODIALYSIS, PERITONEAL DIALYSIS, AND KIDNEY TRANSPLANTATION

    by Damian Zienkiewicz, Gabriela Makulec, Karolina Domosud, Weronika Walendziak, Natalia Mordal, Kacper Ściebura, Wiktoria Wiśniewska, Magdalena Ostaszewska, Milena Majchrzyk, Anna Malczyk

    Chronic kidney disease affects approximately 9.5% of the global population, with end-stage kidney disease requiring renal replacement therapy (RRT). This narrative review synthesizes evidence from recent meta-analyses and landmark studies comparing psychological and psychosocial outcomes across hemodialysis (HD), peritoneal dialysis (PD), and kidney transplantation (KTx). Depression prevalence is approximately 35% in both HD and PD patients, but significantly lower (25%) in KTx recipients, a difference primarily attributable to modality rather than patient characteristics. Cognitive impairment affects 53% of HD patients versus lower rates in PD patients; intradialytic cerebral ischemia emerges as a plausible mechanism, yet paradoxically, PD patients show faster brain atrophy while maintaining better cognitive test performance. Health-related quality of life follows a consistent hierarchy: KTx provides superior outcomes, followed by PD, then HD, with effects most pronounced in kidney-disease-specific domains. Critically, immunosuppressive medication side effects, not graft function, emerge as the strongest predictor of post-transplant quality of life. Major psychosocial domains including employment, sexual function, and sleep quality remain unstudied when stratified by modality. Current modality selection relies on clinical and logistical factors without considering psychological fit. This review identifies substantial evidence gaps and proposes that future practice integrate psychological assessment into pre-dialysis education and develop validated tools to personalize modality selection based on coping capacity and psychological resilience.